Wuchang Zhu

机构：Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University

发表论文 8 篇 · 总被引 81 次 · h-index 5

代表论文

• Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics (2023 · Phytomedicine · 被引 32)
• The Integrated Analysis of Transcriptomics and Metabolomics Unveils the Therapeutical Effect of Asiatic Acid on Alcoholic Hepatitis in Rats (2022 · Inflammation · 被引 20)
• Isovitexin protects against acute liver injury by targeting PTEN, PI3K and BiP via modification of m6A (2022 · European Journal of Pharmacology · 被引 18)
• Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma (2022 · Frontiers in Genetics · 被引 5)
• Asiatic acid ameliorates rifampicin‐ and isoniazid‐induced liver injury in vivo by regulating sphingolipid metabolism and mitogen‐activated protein kinase signalling pathways (2023 · Basic & Clinical Pharmacology & Toxicology · 被引 4)
• Nonlinear Relationship Between the C-Reactive Protein to Albumin Ratio and Chronic Kidney Disease: A Cross-Sectional Analysis Using the NHANES Database (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)